Pioneering trial aims to free kidney patients from lifelong drugs
Disease control
Recruiting now
This early-stage study is testing a new combination treatment designed to help the body accept a donated kidney without needing lifelong anti-rejection drugs. The treatment involves a special bone marrow infusion from the kidney donor, along with medications and low-dose radiatio…
Phase: EARLY_PHASE1 • Sponsor: Tatsuo Kawai, MD, PhD • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC